Last reviewed · How we verify
MI Varnish
At a glance
| Generic name | MI Varnish |
|---|---|
| Also known as | GC MI varnish, Recaldent, primary DI number: D6580052651 |
| Sponsor | King Abdulaziz University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Evaluation of Self-assembling Peptides Versus Amorphous Calcium Phosphate in the Treatment of White Spot Lesions (NA)
- Remineralization Efficacy of Moringa Oleifera Varnish Vs MI Varnish in Initial Carious Lesions Over 6 Months Follow Up: a Randomized Controlled Clinical Trial (NA)
- Efficacy of Different Agents in Treatment of Initial Caries on Smooth Surfaces in Permanent Teeth in Children (PHASE3)
- Effects of Different Remineralization Agents on Molar Incisor Hypomineralization Defects: a Randomized Clinical Study (NA)
- Modified Atraumatic Restorative Treatment Using CPP ACP (NA)
- Remineralization Agents for the Treatment of White Spot Lesions (NA)
- White Spot Lesions Treatment in Orthodontic (PHASE4)
- Silver Diamine Fluoride Versus Sodium Fluoride Varnish With Parental Behavior Modification in Arresting Early Childhood Caries (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MI Varnish CI brief — competitive landscape report
- MI Varnish updates RSS · CI watch RSS
- King Abdulaziz University portfolio CI